Skip to content

Author

L. Martinet

We have 2 of 68 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy.

A multiomic classification of NDMM linked to Isa-KRd response is defined, with a multimodal random forest model outperforming clinical and genomic models and providing comparable discrimination and improved calibration relative to the transcriptomic and epigenomic models.

F. Magrangeas, Mia Cherkaoui, Victor Bessonneau-Gaborit et al. · 0 citations
Open access Sep 2026

Inflammatory bone marrow microenvironment impairs the therapeutic effect of daratumumab-lenalidomide in multiple myeloma

An NF-κB-associated inflammatory axis underlying poor DR response is underscores an NF-κB-associated inflammatory axis underlying poor DR response and suggests that targeting inflammatory pathways a potential therapeutic avenue warranting further investigation.

Wen-Wen Cheng, S. Gaggero, Lama Hasan Bou Issa et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.